IVIM Technology, Inc. Logo

IVIM Technology, Inc.

Provides intravital microscopy systems & CRO services for preclinical research and drug discovery.

460470 | KO

Overview

Corporate Details

ISIN(s):
KR7460470008
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노4로 17, 대덕비즈센터 비동 415호(관평동), 대전광역시
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

IVIM Technology, Inc. is a biotechnology company and a leading global provider of advanced intravital microscopy (IVM) solutions for preclinical research. The company specializes in developing and manufacturing pioneering 'All-in-One' intravital confocal and two-photon microscopy systems. These platforms enable researchers to perform high-resolution, real-time 3D imaging of cellular and molecular dynamics within living organisms, aiming to uncover disease pathophysiology and accelerate the discovery of new treatments. In addition to its product suite, IVIM Technology offers Contract Research Organization (CRO) services, providing its proprietary in vivo imaging technology to support and advance drug development projects. The company's core technology was originally developed at the Korea Advanced Institute of Science and Technology (KAIST).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-10 00:00
Regulatory Filings
단일판매ㆍ공급계약체결
Korean 10.4 KB
2025-08-13 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-08-11 00:00
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
Korean 15.8 KB
2025-08-01 00:00
Regulatory Filings
단일판매ㆍ공급계약체결
Korean 10.0 KB
2025-06-26 00:00
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
Korean 15.9 KB
2025-06-16 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 23.5 KB
2025-05-28 00:00
Regulatory Filings
단일판매ㆍ공급계약체결
Korean 11.4 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB
2025-04-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 72.9 KB
2025-04-23 00:00
Regulatory Filings
단일판매ㆍ공급계약체결
Korean 10.6 KB
2025-04-22 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 27.6 KB
2025-04-15 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 73.0 KB
2025-04-15 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.8 KB
2025-03-26 00:00
AGM Information
정기주주총회결과
Korean 22.0 KB
2025-03-26 00:00
Remuneration Information
주식매수선택권부여에관한신고
Korean 15.9 KB

Automate Your Workflow. Get a real-time feed of all IVIM Technology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IVIM Technology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IVIM Technology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France
COX
NLS Pharmaceutics Ltd. Logo
Developing therapies for rare CNS disorders, specializing in narcolepsy and sleep-wake issues.
United States of America
NLSP
NovoCure Ltd Logo
Develops a non-invasive electric field therapy to disrupt and treat aggressive solid tumor cancers.
United States of America
NVCR
NUFORMIX PLC Logo
Repurposing drugs for fibrosis and oncology using proprietary cocrystal technology.
United Kingdom
NFX
Nurix Therapeutics, Inc. Logo
Developing protein degradation medicines to treat cancer and autoimmune diseases.
United States of America
NRIX
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom
ONC
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
ONCODESIGN Logo
Developing precision oncology solutions for resistant and metastatic cancers.
France
ALONC

Talk to a Data Expert

Have a question? We'll get back to you promptly.